Web siteme hoÅŸ geldiniz
Web siteme hoÅŸ geldiniz
Web siteme hoÅŸ geldiniz
Web siteme hoÅŸ geldiniz
Suzan Farhang-Sardroodi, M.Sc., Ph.D.
Web siteme hoÅŸ geldiniz
Mental health is health
Temerty
Medicine
Web siteme hoÅŸ geldiniz
Amedeo Modigliani
Suzan Farhang-Sardroodi
Department of Pharmacology and Toxicology
Temerty Faculty of Medicine, University of Toronto
I am a Research Associate in the Department of Pharmacology and Toxicology at the University of Toronto. I received my Ph.D. in Physics from the University of Zanjan (Iran) and completed an exchange semester in the Department of Applied Mathematics at the University of Waterloo (Waterloo, Ontario, Canada). I pursued postdoctoral research in quantitative oncology at the Biomathematics and Fluids Group at Toronto Metropolitan University, and in computational immunology at the Departments of Mathematics and Statistics at York University (supervised by Dr. Jane Heffernan and Dr. Iain Moyles, Toronto, Ontario, Canada), the University of Manitob (Winnipeg, Manitoba), and Université de Montréal (supervised by Dr. Morgan Craig, Montréal, Québec, Canada).
Memberships ​​​
I am a member of:
​
-
Steering Committee Member, Centre for Mathematical Medicine, Fields Institute, Toronto, ON, Canada
Term: April 10, 2025 – June 30, 2028
Appointed to the Steering Committee to support interdisciplinary research and initiatives in mathematical medicine, with a focus on Systems Pharmacology & Toxicology​
​
​
-
Member, Temerty Centre for AI Research and Education in Medicine (T-CAIREM), University of Toronto
​​​​​​​
Research Interests
​​​
Women's Cancers, and Brain Health
​​
My research investigates how inherited genetic variation and estrogen signaling influence breast and ovarian cancer susceptibility, treatment response, and long-term brain health. By integrating statistical genetics, functional genomics, and interpretable artificial intelligence, I aim to identify causal molecular mechanisms that enable biomarker discovery and therapeutic target identification. I am particularly interested in understanding how biological pathways shared between women's cancers contribute to neuropsychiatric disorders, cognitive decline, and Alzheimer's disease.